| Literature DB >> 34352223 |
Marica Rosaria Ippolito1, Valentino Martis1, Sara Martin1, Andréa E Tijhuis2, Christy Hong2, René Wardenaar2, Marie Dumont3, Johanna Zerbib4, Diana C J Spierings2, Daniele Fachinetti3, Uri Ben-David4, Floris Foijer2, Stefano Santaguida5.
Abstract
Mitotic errors lead to aneuploidy, a condition of karyotype imbalance, frequently found in cancer cells. Alterations in chromosome copy number induce a wide variety of cellular stresses, including genome instability. Here, we show that cancer cells might exploit aneuploidy-induced genome instability and the resulting gene copy-number changes to survive under conditions of selective pressure, such as chemotherapy. Resistance to chemotherapeutic drugs was dictated by the acquisition of recurrent karyotypes, indicating that gene dosage might play a role in driving chemoresistance. Thus, our study establishes a causal link between aneuploidy-driven changes in gene copy number and chemoresistance and might explain why some chemotherapies fail to succeed.Entities:
Keywords: aneuploidy; cancer; chemotherapy; drug resistance; genome instability
Year: 2021 PMID: 34352223 DOI: 10.1016/j.devcel.2021.07.006
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270